We are live on ! Find out more
IMRX icon

Immuneering
IMRX

38 hedge funds and large institutions have $316M invested in Immuneering in 2021 Q3 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46.67% more ownership

Funds ownership: 0% → 46.67% (+47%)

Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$83.7M
2
CAM
Cormorant Asset Management
Massachusetts
+$60.5M
3
Citadel Advisors
Citadel Advisors
Florida
+$55.2M
4
BlackRock
BlackRock
New York
+$41M
5
RSCM
Rock Springs Capital Management
Maryland
+$29.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$81.2M +$83.7M +3,114,025 New
CAM
2
Cormorant Asset Management
Massachusetts
$58.5M +$60.5M +2,252,626 New
Citadel Advisors
3
Citadel Advisors
Florida
$52.4M +$55.2M +2,055,459 New
BlackRock
4
BlackRock
New York
$40.5M +$41M +1,524,374 New
RSCM
5
Rock Springs Capital Management
Maryland
$28.9M +$29.3M +1,089,816 New
PA
6
Perceptive Advisors
New York
$18.1M +$18.3M +681,051 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$9.12M +$9.23M +343,601 New
Fidelity Investments
8
Fidelity Investments
Massachusetts
$6.64M +$6.72M +250,000 New
SCM
9
Suvretta Capital Management
New York
$5.31M +$5.37M +200,000 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$3.25M +$3.29M +122,319 New
State Street
11
State Street
Massachusetts
$2.69M +$2.72M +101,202 New
Millennium Management
12
Millennium Management
New York
$2.38M +$2.41M +89,788 New
Northern Trust
13
Northern Trust
Illinois
$1.93M +$1.95M +72,612 New
CCM
14
CAAS Capital Management
New York
$1.06M +$1.07M +40,000 New
TD Asset Management
15
TD Asset Management
Ontario, Canada
$911K +$922K +34,296 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$547K +$554K +20,599 New
Charles Schwab
17
Charles Schwab
California
$538K +$544K +20,236 New
GCM
18
Ghisallo Capital Management
Massachusetts
$398K +$403K +15,000 New
KPW
19
Kore Private Wealth
New York
$374K +$379K +14,100 New
Marshall Wace
20
Marshall Wace
United Kingdom
$349K +$353K +13,149 New
N
21
Nuveen
North Carolina
$312K +$316K +11,760 New
Morgan Stanley
22
Morgan Stanley
New York
$178K +$180K +6,708 New
Deutsche Bank
23
Deutsche Bank
Germany
$126K +$128K +4,752 New
AIG
24
American International Group
New York
$120K +$122K +4,526 New
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$119K +$120K +4,468 New
1
2

IMRX Hedge Fund Activity: Q3 2021 in Review

38 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Immuneering (IMRX) for Q3 2021, worth a combined $316M.

Buyers outnumbered sellers: 38 funds opened new IMRX positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $83.7M.

  • 38 institutional investors held Immuneering (IMRX) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $316M of Immuneering stock for Q3 2021.
  • 38 funds opened new Immuneering positions in Q3 2021 and 0 closed out, a net change of +38 holders.
  • The largest Immuneering buyer in Q3 2021 was T. Rowe Price Associates, an estimated $83.7M added.

Based on aggregated 13F filings for Q3 2021.